Shanghai Pharmaceuticals Holding Co. Ltd
Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic a… Read more
Market Cap & Net Worth: Shanghai Pharmaceuticals Holding Co. Ltd (SHPMF)
Shanghai Pharmaceuticals Holding Co. Ltd (PINK:SHPMF) has a market capitalization of $1.44 Billion ($1.44 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #4411 globally and #2766 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Pharmaceuticals Holding Co. Ltd's stock price $1.56 by its total outstanding shares 919073024 (919.07 Million).
Shanghai Pharmaceuticals Holding Co. Ltd Market Cap History: 2015 to 2025
Shanghai Pharmaceuticals Holding Co. Ltd's market capitalization history from 2015 to 2025. Data shows growth from $663.85 Million to $1.44 Billion (5.61% CAGR).
Shanghai Pharmaceuticals Holding Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai Pharmaceuticals Holding Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Shanghai Pharmaceuticals Holding Co. Ltd's market cap is 0.01 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.37x
Shanghai Pharmaceuticals Holding Co. Ltd's market cap is 0.37 times its annual earnings
9.22x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $663.85 Million | $105.52 Billion | $2.88 Billion | 0.01x | 0.23x |
| 2016 | $1.01 Billion | $120.76 Billion | $3.20 Billion | 0.01x | 0.32x |
| 2017 | $1.04 Billion | $130.85 Billion | $3.52 Billion | 0.01x | 0.30x |
| 2018 | $897.02 Million | $159.08 Billion | $3.88 Billion | 0.01x | 0.23x |
| 2019 | $1.09 Billion | $186.57 Billion | $4.08 Billion | 0.01x | 0.27x |
| 2020 | $1.39 Billion | $191.91 Billion | $4.50 Billion | 0.01x | 0.31x |
| 2021 | $1.50 Billion | $215.82 Billion | $5.09 Billion | 0.01x | 0.29x |
| 2022 | $1.35 Billion | $231.98 Billion | $5.62 Billion | 0.01x | 0.24x |
| 2023 | $1.36 Billion | $260.30 Billion | $3.77 Billion | 0.01x | 0.36x |
| 2024 | $1.67 Billion | $275.25 Billion | $4.55 Billion | 0.01x | 0.37x |
Competitor Companies of SHPMF by Market Capitalization
Companies near Shanghai Pharmaceuticals Holding Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shanghai Pharmaceuticals Holding Co. Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Shanghai Pharmaceuticals Holding Co. Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Shanghai Pharmaceuticals Holding Co. Ltd's market cap moved from $663.85 Million to $ 1.44 Billion, with a yearly change of 5.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.44 Billion | -14.18% |
| 2024 | $1.67 Billion | +23.04% |
| 2023 | $1.36 Billion | +0.42% |
| 2022 | $1.35 Billion | -9.69% |
| 2021 | $1.50 Billion | +7.91% |
| 2020 | $1.39 Billion | +28.03% |
| 2019 | $1.09 Billion | +20.96% |
| 2018 | $897.02 Million | -13.73% |
| 2017 | $1.04 Billion | +2.47% |
| 2016 | $1.01 Billion | +52.85% |
| 2015 | $663.85 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Shanghai Pharmaceuticals Holding Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.44 Billion USD |
| MoneyControl | $1.44 Billion USD |
| MarketWatch | $1.44 Billion USD |
| marketcap.company | $1.44 Billion USD |
| Reuters | $1.44 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.